Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Streptococcus canis Cas9 as a genome engineering platform with novel PAM specificity

Streptococcus canis Cas9 as a genome engineering platform with novel PAM specificity

US Patent 12054755 · Granted Aug 6, 2024

Estimated economic value: $37,773,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Applications of engineered streptococcus canis Cas9 variants on single-base PAM 2025
Applications of engineered streptococcus canis Cas9 variants on single-base PAM 2025
Applications of engineered streptococcus canis Cas9 variants on single-base PAM 2025
Compositions comprising a CRISPR nuclease and uses thereof2025
Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (2024
Methods and devices for nucleic acids synthesis2023
Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HA2023
Compositions and methods for high fidelity assembly of nucleic acids2023
Applications of engineered Streptococcus canis Cas9 variants on single-base PAM 2023
Applications of engineered Streptococcus canis Cas9 variants on single-base PAM 2023
Applications of engineered Streptococcus canis Cas9 variants on single-base PAM 2023
Applications of engineered Streptococcus canis Cas9 variants on single-base PAM 2022